Literature DB >> 18397702

In-center daily on-line hemodiafiltration: a 4-year experience in children.

M Fischbach1, C Dheu, L Seuge, S Menouer, J Terzic.   

Abstract

Our daily dialysis program was started in September 2002: in-center daily on-line hemodiafiltration (DIH) was carried out in 3-hour sessions, 5 - 6 times weekly, on-line assessment KT/Vurea of minimal 1.5 per session, polysulfone membranes. 12 children were included: median age 7.4 years (2.10 - 16.8 years), renal residual function less than 3 ml/min/1.73 m2 (Kcreat + Kurea/2), vascular access central catheter (n = 4) or fistula (n = 8), 7/12 being converted from peritoneal dialysis to DIH. Median follow-up on DIH was 11 months (4 - 43 months), endpoint was kidney transplantation (11/12) or transfer to another center (1/12). Monthly assessments of dialysis parameters (KT/Vurea, predialysis phosphatemia), diet survey (3 consecutive days), medications (number of antihypertensive drugs, phosphate chelators, potassium chelators) and statural growth were performed. At start of DIH, diet intake due to medical prescription and limited appetite was restrictive with limitation in water, salt (20 mmol/day), potassium and proteins (median 35 g/day, range 20 - 80 g); only 2/12 children were free of antihypertensive drugs, all received phosphate and potassium chelators, and growth retardation occurred (7/12 in prepubertal children, median height SDS -1.52) despite rhGH therapy (5/12 patients). At the end of DIH, diet was free, protein intake high (2 - 3 g/kg/day, range 30 - 100), 10/12 children were free of antihypertensive drugs, 4/12 received potassium chelators, 1/12 received phosphate chelators. All the prepubertal children at inclusion (n = 7) showed catch-up growth with a median growth rate of 0.8 cm/month (0.5 - 1.6 cm/ month). DIH allowed to maintain predialysis phosphatemia in a low normal range (median 1.23 mmol/l, range 1.65 - 0.63), without (11/12 children) need of phosphate chelators. Thanks to DIH children, parents and team care discovered during DIH a new way of life with motivated children, showing natural compliance (no diet restriction, no or few drugs), and most of all children developing with catch-up of growth.

Entities:  

Mesh:

Year:  2008        PMID: 18397702     DOI: 10.5414/cnp69279

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  11 in total

1.  Interdialytic weight gain in oligoanuric children and adolescents on chronic hemodialysis.

Authors:  Fabio Paglialonga; Silvia Consolo; Maria Albina Galli; Sara Testa; Alberto Edefonti
Journal:  Pediatr Nephrol       Date:  2014-11-15       Impact factor: 3.714

Review 2.  Hypertension and hemodialysis: pathophysiology and outcomes in adult and pediatric populations.

Authors:  Peter N Van Buren; Jula K Inrig
Journal:  Pediatr Nephrol       Date:  2011-02-01       Impact factor: 3.714

Review 3.  Cardiovascular complications in children with chronic kidney disease.

Authors:  Rukshana Shroff; Donald J Weaver; Mark M Mitsnefes
Journal:  Nat Rev Nephrol       Date:  2011-09-13       Impact factor: 28.314

4.  Growth of children with end-stage renal disease undergoing daily hemodialysis.

Authors:  Maria Fernanda Carvalho de Camargo; Cristina Lucia Henriques; Simone Vieira; Shirlei Komi; Eliseth Ribeiro Leão; Paulo Cesar Koch Nogueira
Journal:  Pediatr Nephrol       Date:  2013-11-20       Impact factor: 3.714

5.  Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.

Authors:  Benjamin L Laskin; Guixia Huang; Eileen King; Denis F Geary; Christoph Licht; Joshua P Metlay; Susan L Furth; Tom Kimball; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2017-04-08       Impact factor: 3.714

Review 6.  Hemodialysis in children with end-stage renal disease.

Authors:  Dominik Müller; Stuart L Goldstein
Journal:  Nat Rev Nephrol       Date:  2011-09-06       Impact factor: 28.314

Review 7.  Cardiovascular disease in CKD in children: update on risk factors, risk assessment, and management.

Authors:  Amy C Wilson; Mark M Mitsnefes
Journal:  Am J Kidney Dis       Date:  2009-08       Impact factor: 8.860

Review 8.  Nocturnal intermittent hemodialysis.

Authors:  Julia Thumfart; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2014-08-08       Impact factor: 3.714

9.  Hemodiafiltration in a pediatric nocturnal dialysis program.

Authors:  Julia Thumfart; Christina V Puttkamer; Steffen Wagner; Uwe Querfeld; Dominik Müller
Journal:  Pediatr Nephrol       Date:  2014-02-18       Impact factor: 3.714

10.  Haemodiafiltration-optimal efficiency and safety.

Authors:  Ingrid Ledebo; Peter J Blankestijn
Journal:  NDT Plus       Date:  2009-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.